Creative Planning Intellia Therapeutics, Inc. Transaction History

Creative Planning

  • $103 Billion
  • Q4 2024

A detailed history of Creative Planning transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 21,163 shares of NTLA stock, worth $229,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,163
Previous 12,545 68.7%
Holding current value
$229,830
Previous $257,000 4.28%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$11.41 - $21.09 $98,331 - $181,753
8,618 Added 68.7%
21,163 $246,000
Q3 2024

Oct 11, 2024
BUY
$19.72 - $27.36 $4,160 - $5,772
211 Added 1.71%
12,545 $257,000
Q2 2024

Aug 15, 2024
SELL
$20.02 - $27.22 $101,981 - $138,658
-5,094 Reduced 29.23%
12,334 $276,000
Q1 2024

May 10, 2024
BUY
$23.82 - $32.8 $201,421 - $277,356
8,456 Added 94.25%
17,428 $479,000
Q4 2023

Feb 14, 2024
BUY
$23.16 - $32.34 $202,812 - $283,201
8,757 Added 4073.02%
8,972 $273,000
Q3 2023

Nov 16, 2023
BUY
$31.62 - $45.78 $6,798 - $9,842
215 New
215 $6,000
Q2 2022

Aug 15, 2022
SELL
$38.49 - $76.21 $8,275 - $16,385
-215 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$58.27 - $118.99 $12,528 - $25,582
215 New
215 $16,000
Q4 2021

Feb 11, 2022
SELL
$100.76 - $138.36 $182,375 - $250,431
-1,810 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
$132.37 - $176.78 $239,589 - $319,971
1,810 New
1,810 $243,000
Q2 2020

Jul 23, 2020
SELL
$11.14 - $22.87 $708,069 - $1.45 Million
-63,561 Closed
0 $0
Q1 2020

May 05, 2020
SELL
$9.44 - $15.58 $192,132 - $317,099
-20,353 Reduced 24.25%
63,561 $777,000
Q4 2019

Jan 30, 2020
BUY
$10.43 - $17.67 $4,182 - $7,085
401 Added 0.48%
83,914 $1.23 Million
Q3 2019

Nov 01, 2019
SELL
$13.07 - $18.51 $7,972 - $11,291
-610 Reduced 0.73%
83,513 $1.12 Million
Q2 2019

Jul 26, 2019
BUY
$13.88 - $18.41 $84,668 - $112,301
6,100 Added 7.82%
84,123 $1.38 Million
Q1 2019

Apr 24, 2019
BUY
$12.79 - $17.62 $6,279 - $8,651
491 Added 0.63%
78,023 $1.33 Million
Q4 2018

Feb 01, 2019
SELL
$11.39 - $27.13 $4,089 - $9,739
-359 Reduced 0.46%
77,532 $1.06 Million
Q3 2018

Oct 25, 2018
SELL
$25.78 - $32.6 $12,090 - $15,289
-469 Reduced 0.6%
77,891 $2.23 Million
Q2 2018

Jul 20, 2018
BUY
$20.02 - $30.79 $589,188 - $906,149
29,430 Added 60.15%
78,360 $2.14 Million
Q1 2018

Apr 18, 2018
BUY
$19.43 - $34.95 $9,326 - $16,776
480 Added 0.99%
48,930 $1.03 Million
Q4 2017

Jan 17, 2018
BUY
$17.39 - $31.12 $644,038 - $1.15 Million
37,035 Added 324.44%
48,450 $931,000
Q3 2017

Oct 17, 2017
BUY
$15.16 - $25.75 $173,051 - $293,936
11,415
11,415 $284,000

Others Institutions Holding NTLA

# of Institutions
336
Shares Held
96.1M
Call Options Held
1.06M
Put Options Held
863K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $825M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email